A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic ...
Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. This poor prognosis stems ...
Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...
A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...
2d
News-Medical.Net on MSNNeuropeptide Y identified as key driver of pancreatic cancer spreadResearchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...
A new technology from researchers at the California NanoSystems Institute at UCLA is aiming to turn the tables on tumors that ...
GlobalData on MSN12d
Tumour-on-chip model could help discover pancreatic cancer therapiesA team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ...
Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results